Transglutaminase-mediated remodeling of the human erythrocyte membrane skeleton: Relevance for erythrocyte diseases with shortened cell lifespan

Advances in Enzymology and Related Areas of Molecular Biology

Volumn 78 1, Issue , 2011, Pages 385-414

  Lor, Laszlo ^a   Murthy, S N Prasanna ^a   Khan, Anwar A ^a   Xue, Weihua ^a   Lockridge, Oksana ^a   Chishti, Athar H ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

GUANINE NUCLEOTIDE BINDING PROTEIN; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE 2;

APOPTOSIS; BIOLOGICAL MODEL; CELL SURVIVAL; ERYTHROCYTE; ERYTHROCYTE DEFORMABILITY; ERYTHROCYTE MEMBRANE; GENETICS; HEMATOLOGIC DISEASE; HUMAN; MEMBRANE FLUIDITY; METABOLISM; PATHOLOGY; PHYSIOLOGY; REVIEW; ULTRASTRUCTURE;

APOPTOSIS; CELL SURVIVAL; ERYTHROCYTE DEFORMABILITY; ERYTHROCYTE MEMBRANE; ERYTHROCYTES; GTP-BINDING PROTEINS; HEMATOLOGIC DISEASES; HUMANS; MEMBRANE FLUIDITY; MODELS, BIOLOGICAL; TRANSGLUTAMINASES;

EID: 84856620412     PISSN: 0065258X     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Article

References (55)

1. Lorand, L., Dailey, J. E., and Turner, P. M. (1988) Fibronectin as a carrier for the transglutaminase from human erythrocytes, Proc. Natl. Acad. Sci. USA 85, 1057-1059.
2. Turner, P.M. and Lorand, L. (1989) Complexation of fibronectin with tissue transglutaminase, Biochemistry 28, 628-635.
3. LeMosy, E. K., Erickson, H. P., Beyer,W. F. Jr., Radek, J. T., Jeong, J. M.,Murthy, S. N., and Lorand, L. (1992) Visualization of purified fibronectin-transglutaminase complexes, J. Biol. Chem. 267, 7880-7885.
4. Hang, J., Zemskov, E. A., Lorand, L., and Belkin, A. M. (2005) Identification of a novel recognition sequence for fibronectin within the NH2-terminal beta-sandwich domain of tissue transglutaminase, J. Biol. Chem. 280, 23675-23683.
5. Radek, J. T., Jeong, J. M., Murthy, S. N., Ingham, K. C., and Lorand, L. (1993) Affinity of human erythrocyte transglutaminase for a 42-kDa gelatin-binding fragment of human plasma fibronectin, Proc. Natl. Acad. Sci. U S A 90, 3152-3156.
6. Akimov, S. S. and Belkin, A. M. (2001) Cell-surface transglutaminase promotes fibronectin assembly via interaction with the gelatin-binding domain of fibronectin: a role in TGFbeta-dependent matrix deposition, J. Cell Sci. 114, 2989-3000.
7. Murthy, S. N. and Lorand, L. (2000) Nucleotide binding by the erythrocyte transglutaminase/ Gh protein, probed with fluorescent analogs of GTP and GDP, Proc. Natl. Acad. Sci. USA 97, 7744-7747.
8. Murthy, S. N., Velasco, P. T., and Lorand, L. (1998) Properties of purified lens transglutaminase and regulation of its transamidase/crosslinking activity by GTP, Exp. Eye Res. 67, 273-281.
9. Murthy, S. N., Lomasney, J. W., Mak, E. C., and Lorand, L. (1999) Interactions of G(h)/transglutaminase with phospholipase Cdelta1 and with GTP, Proc. Natl. Acad. Sci. USA 96, 11815-11819.
10. Lorand, L., Weissmann, L. B., Epel, D. L., and Bruner-Lorand, J. (1976) Role of the intrinsic transglutaminase in the Ca2+-mediated crosslinking of erythrocyte proteins, Proc. Natl. Acad. Sci. USA 73, 4479-4481.
11. Lorand, L., Weissmann, L. B., Bruner-Lorand, J., and Epel, D. L. (1976) Role of Intracellular transglutaminase in Ca2+-mediated cross-linking of erythrocyte-membrane proteins, Biol. Bull. 151, 419.
12. Anderson, D. R., Davis, J. L., and Carraway, K. L. (1977) Calcium-promoted changes of the human erythrocyte membrane. Involvement of spectrin, transglutaminase, and a membrane-bound protease, J. Biol. Chem. 252, 6617-6623.
13. Siefring, G. E. Jr., Apostol, A. B., Velasco, P. T., and Lorand, L. (1978) Enzymatic basis for the Ca2+-induced cross-linking of membrane proteins in intact human erythrocytes, Biochemistry 17, 2598-2604.14.
14. Coetzer, T. L. and Zail, S. S. (1979) Cross-linking of membrane proteins of metabolically depleted and calcium-loaded erythrocytes, Br. J. Haematol. 43, 375-390.
15. Smith, B. D., La Celle, P. L., Siefring, G. E. Jr., Lowe-Krentz, L., and Lorand, L. (1981) Effects of the calcium-mediated enzymatic cross-linking of membrane proteins on cellular deformability, J. Membr. Biol. 61, 75-80.
16. Miller, D. R.,Weed, R. I., Stamatoyannopoulos, G., and Yoshida, A. (1971) Hemoglobin Koln disease occurring as a fresh mutation: erythrocyte metabolism and survival, Blood 38, 715-729.
17. Pedersen, P. R., McCurdy, P. R., Wrightstone, R. N., Wilson, J. B., Smith, L. L., and Huisman, T. H. (1973) Hemoglobin Koln in a black: pre- and post-splenectomy red cell survival (DF32P and 51Cr) and the pathogenesis of hemoglobin instability, Blood 42, 771-781.
18. Lorand, L., Michalska, M., Murthy, S. N., Shohet, S. B., and Wilson, J. (1987) Crosslinked polymers in the red cell membranes of a patient with Hb-Koln disease, Biochem. Biophys. Res. Commun. 147, 602-607.
19. Shen, L. and Lorand, L. (1983) Contribution of fibrin stabilization to clot strength. Supplementation of factor XIII-deficient plasma with the purified zymogen, J. Clin. Invest. 71, 1336-1341.
20. Lorand, L. (2005) Factor XIII and the clotting of fibrinogen: from basic research to medicine, J Thromb. Haemost. 3, 1337-1348.
21. Lorand, L., Siefring, G. E. Jr., and Lowe-Krentz, L. (1980) Ca2+-triggered and enzyme mediated cross-linking of membrane proteins in intact human erythrocytes. In: Membrane Transport in Erythrocytes, eds Lassen, U. V., Ussing, H. H., andWeith, J. O.Munksgaard, Copenhagen; Vol. 14, pp. 285-299.
22. Lorand, L. and Conrad, S. M. (1984) Transglutaminases, Mol. Cell. Biochem. 58, 9-35.
23. Lorand, L. and Graham, R. M. (2003) Transglutaminases: crosslinking enzymes with pleiotropic functions, Nat. Rev. Mol. Cell Biol. 4, 140-156.
24. Lorand, L. (2001) Factor XIII: structure, activation, and interactions with fibrinogen and fibrin, Ann. NY Acad. Sci. 936, 291-311.
25. Lorand, L., Bjerrum, O. J., Hawkins, M., Lowe-Krentz, L., and Siefring, G. E. Jr. (1983) Degradation of transmembrane proteins in Ca2+-enriched human erythrocytes. An immunochemical study, J. Biol. Chem. 258, 5300-5305.
26. Glaser, T. and Kosower, N. S. (1986) Calpain-calpastatin and fusion. Fusibility of erythrocytes is determined by a protease-protease inhibitor [calpain-calpastatin] balance, FEBS Lett. 206, 115-120.
27. Kosower, N. S., Glaser, T., and Kosower, E. M. (1983) Membrane-mobility agentpromoted fusion of erythrocytes: fusibility is correlated with attack by calcium-activated cytoplasmic proteases on membrane proteins, Proc. Natl. Acad. Sci. USA 80, 7542- 7546.
28. Sarang, Z., Madi, A., Koy, C., Varga, S., Glocker, M. O., Ucker, D. S., Kuchay, S., Chishti, A. H., Melino, G., Fesus, L., and Szondy, Z. (2007) Tissue transglutaminase (TG2) facilitates phosphatidylserine exposure and calpain activity in calcium-induced death of erythrocytes, Cell Death Differ. 14, 1842-1844.
29. Lorand, L. and Michalska, M. (1985) Altered response of stored red cells to Ca2+ stress, Blood 65, 1025-1027.
30. Lorand, L., Barnes, N., Bruner-Lorand, J. A., Hawkins, M., and Michalsk a, M. (1987) Inhibition of protein cross-linking in Ca2+-enriched human erythrocytes and activated platelets, Biochemistry 26, 308-313.
31. Bjerrum, O. J., Hawkins, M., Swanson, P., Griffin, M., and Lorand, L. (1981) An immunochemical approach for the analysis of membrane protein alterations in Ca2+-loaded human erythrocytes, J. Supramol. Struct. Cell. Biochem. 16, 289-301.
32. Moroi, M., Inoue, N., and Yamasaki, M. (1975) Analysis of the fibrin-polymerizing reaction using sodium dodecylsulfate-agarose gel electrophoresis, Biochim. Biophys. Acta 379, 217-226.
33. Korponay-Szabo, I. R., Vecsei, Z., Kiraly, R., Dahlbom, I., Chirdo, F., Nemes, E., Fesus, L., and Maki,M. (2008) Deamidated gliadin peptides form epitopes that transglutaminase antibodies recognize, J. Pediatr. Gastroenterol. Nutr. 46, 253-261.
34. Perkins, D. N., Pappin, D. J., Creasy, D. M., and Cottrell, J. S. (1999) Probability-based protein identification by searching sequence databases using mass spectrometry data, Electrophoresis 20, 3551-3567.
35. Korsgren, C. and Cohen, C. M. (1991) Organization of the gene for human erythrocyte membrane protein 4.2: structural similarities with the gene for the a subunit of factor XIII, Proc. Natl. Acad. Sci. USA 88, 4840-4844.
36. Sung, L. A., Chien, S., Chang, L. S., Lambert, K., Bliss, S. A., Bouhassira, E. E., Nagel, R. L., Schwartz, R. S., and Rybicki, A. C. (1990) Molecular cloning of human protein 4.2: a major component of the erythrocyte membrane, Proc. Natl. Acad. Sci. USA 87, 955-959.
37. Gutierrez, E. and Sung, L. A. (2007) Interactions of recombinant mouse erythrocyte transglutaminase with membrane skeletal proteins, J. Membr. Biol. 219, 93- 104.
38. Khan, A. A., Hanada, T., Mohseni, M., Jeong, J. J., Zeng, L., Gaetani, M., Li, D., Reed, B. C., Speicher, D. W., and Chishti, A. H. (2008) Dematin and adducin provide a novel link between the spectrin cytoskeleton and human erythrocyte membrane by directly interacting with glucose transporter-1, J. Biol. Chem. 283, 14600-14609.
39. Iismaa, S. E., Mearns, B. M., Lorand, L., and Graham, R. M. (2009) Transglutaminases and disease: lessons from genetically engineered mouse models and inherited disorders, Physiol. Rev. 89, 991-1023.
40. Murthy, S. N., Wilson, J., Zhang, Y., and Lorand, L. (1994) Residue Gln-30 of human erythrocyte anion transporter is a prime site for reaction with intrinsic transglutaminase, J. Biol. Chem. 269, 22907-22911.
41. Tsai, I. H., Murthy, S. N., and Steck, T. L. (1982) Effect of red cell membrane binding on the catalytic activity of glyceraldehyde-3-phosphate dehydrogenase, J. Biol. Chem. 257, 1438-1442.
42. Murthy, S. N., Liu, T., Kaul, R. K., Kohler, H., and Steck, T. L. (1981) The aldolasebinding site of the human erythrocyte membrane is at the NH2 terminus of band 3, J. Biol. Chem. 256, 11203-11208.
43. Kliman, H. J. and Steck, T. L. (1980) Association of glyceraldehyde-3-phosphate dehydrogenase with the human red cell membrane. A kinetic analysis, J. Biol. Chem. 255, 6314-6321.
44. Strapazon, E. and Steck, T. L. (1976) Binding of rabbit muscle aldolase to band 3, the predominant polypeptide of the human erythrocyte membrane, Biochemistry 15, 1421-1424.
45. Strapazon, E. and Steck, T. L. (1977) Interaction of the aldolase and the membrane of human erythrocytes, Biochemistry 16, 2966-2971.
46. Chu, H. and Low, P. S. (2006) Mapping of glycolytic enzyme-binding sites on human erythrocyte band 3, Biochem. J. 400, 143-151.
47. Orru, S., Ruoppolo, M., Francese, S., Vitagliano, L., Marino, G., and Esposito, C. (2002) Identification of tissue transglutaminase-reactive lysine residues in glyceraldehyde-3-phosphate dehydrogenase, Protein Sci. 11, 137-146.
48. Samokhin, G. P. and Lorand, L. (1995) Contact with the N termini in the central E domain enhances the reactivities of the distal D domains of fibrin to factor XIIIa, J. Biol. Chem. 270, 21827-21832.
49. Kroemer, G., Galluzzi, L., Vandenabeele, P., Abrams, J., Alnemri, E. S., Baehrecke, E. H., Blagosklonny, M. V., El-Deiry,W. S., Golstein, P., Green, D. R., Hengartner,M., Knight, R. A., Kumar, S., Lipton, S. A., Malorni, W., Nunez, G., Peter, M. E., Tschopp, J., Yuan, J., Piacentini, M., Zhivotovsky, B., and Melino, G. (2009) Classification of cell death: recommendations of the Nomenclature Committee on Cell Death 2009, Cell Death Differ. 16, 3-11.
50. Begg, G. E., Carrington, L., Stokes, P. H., Matthews, J. M., Wouters, M. A., Husain, A., Lorand, L., Iismaa, S. E., and Graham, R. M. (2006) Mechanism of allosteric regulation of transglutaminase 2 by GTP, Proc. Natl. Acad. Sci. USA 103, 19683-19688.
51. Pinkas, D. M., Strop, P., Brunger, A. T., and Khosla, C. (2007) Transglutaminase 2 undergoes a large conformational change upon activation, PLoS Biol. 5, e327, 2788-2796.
52. Bergamini, C. M., Signorini, M., and Poltronieri, L. (1987) Inhibition of erythrocyte transglutaminase by GTP, Biochim. Biophys. Acta 916, 149-151.
53. Andrews, D. A., Yang, L., and Low, P. S. (2002) Phorbol ester stimulates a protein kinase C-mediated agatoxin-TK-sensitive calcium permeability pathway in human red blood cells, Blood 100, 3392-3399.
54. Swislocki,N. I. and Tierney, J. M. (1985) Covalent modification of membrane components during erythrocyte aging, Prog. Clin. Biol. Res. 195, 195-211.
55. Eaton, J. W., Skelton, T. D., Swofford, H. S., Kolpin, C. E., and Jacob, H. S. (1973) Elevated erythrocyte calcium in sickle cell disease, Nature 246, 105-106.